Items where authors include "Black, D.M."

Article

Schini, M. orcid.org/0000-0003-2204-2095, Lui, L.-Y., Vilaca, T. orcid.org/0000-0002-9227-6076 et al. (6 more authors) (2025) The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 40 (3). pp. 307-314. ISSN 0884-0431

Vilaca, T. orcid.org/0000-0002-9227-6076, Schini, M. orcid.org/0000-0003-2204-2095, Lui, L.-Y. et al. (7 more authors) (2024) The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 39 (10). pp. 1434-1442. ISSN 0884-0431

Schini, M. orcid.org/0000-0003-2204-2095, Vilaca, T. orcid.org/0000-0002-9227-6076, Lui, L.-Y. et al. (7 more authors) (2024) Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. Journal of Bone and Mineral Research, 39 (7). pp. 867-876. ISSN 0884-0431

Schini, M. orcid.org/0000-0003-2204-2095, Vilaca, T. orcid.org/0000-0002-9227-6076, Vittinghoff, E. et al. (7 more authors) (2024) Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project. Journal of Bone and Mineral Research, 39 (5). pp. 544-550. ISSN 0884-0431

Eastell, R. orcid.org/0000-0002-0323-3366, Black, D.M., Lui, L. et al. (9 more authors) (2021) Treatment‐related changes in bone turnover and fracture risk reduction in clinical trials of antiresorptive drugs: proportion of treatment effect explained. Journal of Bone and Mineral Research, 36 (2). pp. 236-243. ISSN 0884-0431

Black, D.M., Geiger, E.J., Eastell, R. orcid.org/0000-0002-0323-3366 et al. (5 more authors) (2020) Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. New England Journal of Medicine, 383 (8). pp. 743-753. ISSN 0028-4793

Kim, T.Y., Bauer, D.C., McNabb, B.L. et al. (4 more authors) (2019) Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT Extension I trials. Journal of Bone and Mineral Research, 34 (5). pp. 810-816. ISSN 0884-0431

Eastell, R. orcid.org/0000-0002-0323-3366, Mitlak, B.H., Wang, Y. et al. (3 more authors) (2019) Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE. Osteoporosis International, 30 (3). pp. 667-673. ISSN 0937-941X

Yang, L. orcid.org/0000-0002-7916-1418, Parimi, N., Orwoll, E.S. et al. (4 more authors) (2018) Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study. Osteoporosis International, 29. pp. 643-651. ISSN 0937-941X

Yang, L., Palermo, L., Black, D.M. et al. (1 more author) (2014) Prediction of Incident Hip Fracture with the Estimated Femoral Strength by Finite Element Analysis of DXA Scans in the Study of Osteoporotic Fractures. Journal of Bone and Mineral Research (JBMR), 29 (12). pp. 2594-2600. ISSN 0884-0431

Jacques, R.M., Boonen, S., Cosman, F. et al. (4 more authors) (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research, 27 (8). 1627 - 1634. ISSN 1523-4681

Boonen, S., Eastell, R. orcid.org/0000-0002-0323-3366, Su, G. et al. (8 more authors) (2012) Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. Journal of Bone and Mineral Research , 27 (7). pp. 1487-1493. ISSN 0884-0431

Proceedings Paper

Vilaca, T., Toronjo Schini, M., Thompson, A.R. et al. (7 more authors) (2024) 7867 Treatment-related changes in total hip bone mineral density and fracture risk reduction for drugs with different mechanisms of action: the FNIH-ASBMR-SABRE project. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .